February 2023 in “Journal of The American Academy of Dermatology” This study found that transgender and gender diverse patients on masculinizing hormone therapy had 2.5 times the rate of androgenetic alopecia compared to cisgender women.
1 citations
,
October 2021 in “Journal of The American Academy of Dermatology” This review discusses treatment options for androgenetic alopecia in transgender and gender-diverse patients, highlighting first-line treatments like topical minoxidil and finasteride, but reports no new clinical results.
August 2025 in “Journal of Affective Disorders” This study found that gender-diverse individuals experienced higher depression and anxiety levels alongside lower cortisol concentrations, resembling profiles typical in trauma and pain-related conditions.
August 2025 in “Journal of the American Academy of Dermatology” Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.
April 2026 in “Dermatology and Therapy” This paper argues that androgenetic alopecia in transgender and gender-diverse individuals is clinically significant, suggesting individualized and gender-affirming treatment approaches, with oral minoxidil as a key therapy.
